Publications by authors named "Philipp Oster"

Claim this Profile
M
Modeling antibody persistence after MenACYW-TT vaccination and comparative analysis with other quadrivalent meningococcal vaccines.
Laurent Coudeville, Isabelle Bertrand-Gerentes, Céline Zocchetti, Edith Langevin, Siham Bchir, Philipp Oster

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune persistence and booster response of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) 5 years after primary vaccination of adults at ≥56 years of age.
Corwin A Robertson, Jeffry Jacqmein, Alexandre Selmani, Katherine Galarza, Philipp Oster

Hum Vaccin Immunother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study.
Corwin A Robertson, Jeffry Jacqmein, Alexandre Selmani, Katherine Galarza, Philipp Oster

Hum Vaccin Immunother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial.
Markus Knuf, Mika Rämet, Nina Breinholt Stærke, Isabelle Bertrand-Gerentes, Yaël Thollot, Philipp Oster

Hum Vaccin Immunother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age.
Gary S Marshall, Stephen I Pelton, Corwin A Robertson, Philipp Oster

Hum Vaccin Immunother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Contracting Invasive Meningococcal Disease and Related Mortality: A Systematic Literature Review and Meta-analysis.
Himanshu Dubey, Philipp Oster, Mir Sohail Fazeli, Sandra Guedes, Paul Serafini

Int J Infect Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.
Sandra Guedes, Isabelle Bertrand-Gerentes, Keith Evans, Florence Coste, Philipp Oster

BMC Public Health· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT.
Federico Martinón-Torres, Isabelle Bertrand-Gerentes, Philipp Oster

Expert Rev Vaccines· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Safety of a Two-Dose Series of a Meningococcal (Groups A, C, W, and Y) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Men-ACWY-D) in Healthy Japanese Adults.
Osamu Matsuoka, Daisuke Tsuzuki, Katsuhisa Suzuki, Tomoyuki Tanaka, Yoshiharu Takagi, Philipp Oster

Jpn J Infect Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal study of meningococcal carriage rates in university entrants living in a dormitory in South Korea.
Heun Choi, Hyuk Min Lee, Woonji Lee, Jun Hyoung Kim, Hye Seong, Philipp Oster

PLoS One· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study.
Feng-Cai Zhu, Yue-Mei Hu, Ya-Nan Li, Jean-Denis Shu, Philipp Oster

Hum Vaccin Immunother· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Marketing Surveillance Observational Study of Quadrivalent Meningococcal Diphtheria Toxoid Conjugate Vaccine (MenACWY-DT, MCV4/Menactra) in the Republic of Korea, 2014-2019.
Hee Soo Kim, Solene Engel, David Neveu, Yael Thollot, Philipp Oster

Infect Dis Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The global meningitis genome partnership.
Elizabeth Rodgers, Stephen D Bentley, Ray Borrow, Holly B Bratcher, Sylvain Brisse, Philipp Oster

J Infect· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Safety and Immunogenicity Study of a Single Dose of a Meningococcal (Groups A, C, W, and Y) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MEN-ACWY-D) in Healthy Japanese Participants.
Shinji Fukushima, Hitoshi Kikuchi, Mitsunobu Miyazu, Atsuo Hamada, Kazunobu Ouchi, Philipp Oster

Jpn J Infect Dis· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a single dose of a quadrivalent meningococcal conjugate vaccine (MenACYW-D): a multicenter, blind-observer, randomized, phase III clinical trial in the Republic of Korea.
Dong Soo Kim, Min Ja Kim, Sung-Ho Cha, Hwang Min Kim, Jong-Hyun Kim, Philipp Oster

Int J Infect Dis· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meningococcal serogroup C serum and salivary antibody responses to meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with bivalent and quadrivalent meningococcal polysaccharide vaccine.
Mohamed Khalil, Yagob Al-Mazrou, Helen Findlow, Helen Chadha, Valerie Bosch Castells, Philipp Oster

Vaccine· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of two doses of quadrivalent meningococcal conjugate vaccine or one dose of meningococcal group C conjugate vaccine, both administered concomitantly with routine immunization to 12- to 18-month-old children.
Francisco Noya, Deirdre McCormack, Donna L Reynolds, Dion Neame, Philipp Oster

Can J Infect Dis Med Microbiol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future.
Johan Holst, Philipp Oster, Richard Arnold, Michael V Tatley, Lisbeth M Næss

Hum Vaccin Immunother· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers.
Catherine Jackson, Diana Lennon, Sharon Wong, Jacqueline Yan, Joanna Stewart, Philipp Oster

Arch Dis Child· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults.
Daniela Toneatto, Philipp Oster, A Corine W deBoer, Amy Emerson, George F Santos

Hum Vaccin· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans.
Daniela Toneatto, Shevqet Ismaili, Ellen Ypma, Kay Vienken, Philipp Oster

Hum Vaccin· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.
Matthew D Snape, Tom Dawson, Philipp Oster, Anita Evans, Tessa M John

Pediatr Infect Dis J· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.
Jamie Findlow, Ray Borrow, Matthew D Snape, Tom Dawson, Ann Holland, Philipp Oster

Clin Infect Dis· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.
Marzia M Giuliani, Alessia Biolchi, Davide Serruto, Francesca Ferlicca, Kay Vienken, Philipp Oster

Vaccine· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine.
Jay Lucidarme, Maurizio Comanducci, Jamie Findlow, Stephen J Gray, Edward B Kaczmarski, Philipp Oster

Clin Vaccine Immunol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis